ArticleMolecules (Basel, Switzerland)2022
DAD-Net: Classification of Alzheimer's Disease Using ADASYN Oversampling Technique and Optimized Neural Network.
Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 59 citations in OpenAlex.
- Machine Learning-Based Pitting Rate Classification and Prediction for 316L Stainless Steel in NaClOMaterials (Basel, Switzerland) · 2026Article
- Strategies for Class-Imbalanced Learning in Multi-Sensor Medical Imaging.Sensors (Basel, Switzerland) · 2026Review
- AlzhiNet: Traversing from 2D-CNN to 3D-CNN, Towards Early Detection and Diagnosis of Alzheimer's Disease.Interdisciplinary sciences, computational life sciences · 2026Article
- Article
- Potential of AI-based diagnostic grading system for knee osteoarthritis.Frontiers in medicine · 2025Article
- Early detection and classification of Alzheimer's disease through data fusion of MRI and DTI images using the YOLOv11 neural network.Frontiers in neuroscience · 2025Article
- Development and validation of a practical prediction model for post-ERCP pancreatitis using machine learning.Frontiers in surgery · 2025Article
- InGSA: integrating generalized self-attention in CNN for Alzheimer's disease classification.Frontiers in artificial intelligence · 2025Article
- Psychiatric disorders from EEG signals through deep learning models.IBRO neuroscience reports · 2024Article
- Computational imaging for rapid detection of grade-I cerebral small vessel disease (cSVD).Heliyon · 2024Article
- Alzheimer Disease Detection Studies: Perspective on Multi-Modal Data.Yearbook of medical informatics · 2024Review
- Prediction of Alzheimer's disease stages based on ResNet-Self-attention architecture with Bayesian optimization and best features selection.Frontiers in computational neuroscience · 2024Article
- Advanced interpretable diagnosis of Alzheimer's disease using SECNN-RF framework with explainable AI.Frontiers in artificial intelligence · 2024Article
- Accurate Detection of Alzheimer's Disease Using Lightweight Deep Learning Model on MRI Data.Diagnostics (Basel, Switzerland) · 2023Article
- Deep learning interpretability in neuroimaging: A comprehensive survey and methodological recommendations.Imaging neuroscience (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 8 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's Disease (AD) is a neurological brain disorder that causes dementia and neurological dysfunction, affecting memory, behavior, and cognition. Deep Learning (DL), a kind of Artificial Intelligence (AI), has paved the way for new AD detection and automation methods. The DL model's prediction accuracy depends on the dataset's size. The DL models lose their accuracy when the dataset has an imbalanced class problem. This study aims to use the deep Convolutional Neural Network (CNN) to develop a reliable and efficient method for identifying Alzheimer's disease using MRI. In this study, we offer a new CNN architecture for diagnosing Alzheimer's disease with a modest number of parameters, making it perfect for training a smaller dataset. This proposed model correctly separates the early stages of Alzheimer's disease and displays class activation patterns on the brain as a heat map. The proposed Detection of Alzheimer's Disease Network (DAD-Net) is developed from scratch to correctly classify the phases of Alzheimer's disease while reducing parameters and computation costs. The Kaggle MRI image dataset has a severe problem with class imbalance. Therefore, we used a synthetic oversampling technique to distribute the image throughout the classes and avoid the problem. Precision, recall, F1-score, Area Under the Curve (AUC), and loss are all used to compare the proposed DAD-Net against DEMENET and CNN Model. For accuracy, AUC, F1-score, precision, and recall, the DAD-Net achieved the following values for evaluation metrics: 99.22%, 99.91%, 99.19%, 99.30%, and 99.14%, respectively. The presented DAD-Net outperforms other state-of-the-art models in all evaluation metrics, according to the simulation results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.